Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04907968
Title Study of Upifitamab Rilsodotin in Combination With Other Agent(s) in Participants With High-grade Serous Ovarian Cancer (UPGRADE)
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Mersana Therapeutics
Indications

fallopian tube cancer

ovarian cancer

peritoneum cancer

Therapies

Carboplatin + XMT-1536

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.